Skip to content

AptarGroup ATR Finished goods

Finished goods at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
Baxter International logo
Baxter InternationalBAX
AVT
AvantorAVTR
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
DuPont de Nemours, Inc. logo
DuPont de Nemours, Inc.DD
IR
Ingersoll RandIR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's finished goods?
AptarGroup (ATR) reported finished goods of $201.7M in Q1 2026.
How has AptarGroup's finished goods changed year-over-year?
AptarGroup's finished goods increased by 17.2% year-over-year, from $172.1M to $201.7M.
What is the long-term trend for AptarGroup's finished goods?
Over 5 years (2020 to 2025), AptarGroup's finished goods has grown at a 5.3% compound annual growth rate (CAGR), from $147.48M to $191.1M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.